| Formulary Chapter 3: Respiratory system - Full Section
|
| Useful Links |
 NICE NG80: Asthma: diagnosis, monitoring and chronic asthma management |
 NICE CG101: COPD guideline |
|
NICE NG115: Chronic obstructive pulmonary disease in over 16s: diagnosis and management |
|
NICE NG166: COVID-19 rapid guideline: severe asthma |
|
NICE TA10: Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma |
|
NICE TA38: Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years) |
| Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
|
03.01 |
Bronchodilators (0,0)
|
|
|
Asthma (0,0)
|
|
|
Chronic obstructive pulmonary disease (0,0)
|
|
|
Croup (0,0)
|
|
03.01.01 |
Adrenoceptor agonists (0,0)
|
|
03.01.01.01 |
Selective Beta2 agonists
(5,0)
|
|
|
Short-acting beta2 agonists (0,0)
|
|
|
Long-acting beta2 agonists (0,0)
|
|
03.01.01.02 |
Other adrenoceptor agonists
(1,0)
|
|
03.01.02 |
Antimuscarinic bronchodilators
(6,0)
|
|
03.01.03 |
Theophylline
(3,0)
|
|
03.01.04 |
Compound bronchodilator preparations
(3,0)
|
|
03.01.05 |
Peak flow meters, inhaler devices and nebulisers (0,0)
|
|
|
Peak flow meters
(1,0)
|
|
|
Drug delivery devices
(3,0)
|
|
|
Nebulisers (0,0)
|
|
|
Nebuliser Diluent
(1,0)
|
|
03.02 |
Corticosteroids
(11,1)
|
|
03.03 |
Cromoglicate, related therapy and leukotriene receptor antagonists (0,0)
|
|
03.03.01 |
Cromoglicate and related therapy (0,0)
|
|
|
Related therapy (0,0)
|
|
03.03.02 |
Leukotriene receptor antagonists
(1,0)
|
|
03.03.03 |
Phosphodiesterase type-4 inhibitors (0,0)
|
|
03.04 |
Antihistamines, hyposensitisation, and allergic emergencies (0,0)
|
|
03.04.01 |
Antihistamines (0,0)
|
|
|
Non-sedating antihistamines
(3,0)
|
|
|
Sedating antihistamins
(5,0)
|
|
03.04.02 |
Allergen Immunotherapy (0,0)
|
|
|
Omalizumab
(1,0)
|
|
03.04.03 |
Allergic emergencies (0,0)
|
|
|
Anaphylaxis
(3,0)
|
|
|
Angioedema (0,0)
|
|
|
Self-administration of adrenaline (epinephrine)
(1,0)
|
|
03.05 |
Respiratory stimulants and pulmonary surfactants (0,0)
|
|
03.05.01 |
Respiratory stimulants
(1,0)
|
|
03.05.02 |
Pulmonary surfactants
(1,0)
|
|
03.06 |
Oxygen (0,0)
|
|
03.07 |
Mucolytics
(1,0)
|
|
|
Dornase alfa
(1,0)
|
|
|
Hypertonic Sodium Chloride
(1,0)
|
|
|
Mannitol (0,0)
|
|
03.08 |
Aromatic inhalations
(1,0)
|
|
03.09 |
Cough preparations (0,0)
|
|
03.09.01 |
Cough suppressants
(3,0)
|
|
|
Palliative care
(1,0)
|
|
03.09.02 |
Expectorant and demulcent cough preparations
(1,0)
|
|
03.10 |
Systemic nasal decongestants
(1,0)
|
